首页> 外文期刊>Clinical practice and epidemiology in mental health >Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy
【24h】

Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy

机译:慢性丙型肝炎与重度抑郁症的关联:不论α-干扰素治疗

获取原文
           

摘要

Background Mood and anxiety symptoms in chronic hepatitis C (CHC) may be related to the patient awareness of the diagnosis and prognosis, to side effects induced by interferon (IFN)-alpha treatment, as well as to substance abuse. However, the observation of metabolic alterations in patients with CHC has led to hypothesize a direct effect of hepatitis C virus (HCV) on brain function. This study was aimed at elucidating whether CHC is associated with specific anxiety or mood disorders independently of confounding factors. Methods Patient cohort: consecutive patients, 135 with CHC and 76 with chronic hepatitis B (CHB). Exclusion criteria: previous treatment with IFN-alpha, co-infection with HCV and hepatitis B virus, infection with human immunodeficiency virus, drug or alcohol abuse, or malignancies. Controls: subjects without evidence of hepatitis randomly extracted from the database of a previous epidemiological study; they were divided into two groups of 540 (332 males) and 304 (220 males) as controls for patients with CHC and CHB, respectively. The psychiatric diagnosis was formulated by means of the Composite International Diagnostic Interview Simplified carried out by a physician according to DSM-IV criteria. Results A higher lifetime prevalence of major depressive disorder (MDD) was observed among CHC compared to CHB or controls. The risk of MDD was not statistically different between CHB and controls. Both the CHC and CHB groups showed a significantly higher frequency of panic disorder when compared to controls. No statistical differences were observed in the prevalence of general anxiety disorder and social phobia when CHC or CHB were compared to controls. Conclusion The present study provides the first evidence of an association between CHC and MDD, diagnosed on the basis of well-defined international criteria. This association is independent of treatment with IFN-alpha and is not influenced by substance or alcohol abuse. By contrast, anxiety disorders do not appear to be specifically associated with CHC.
机译:背景慢性丙型肝炎(CHC)的情绪和焦虑症状可能与患者对诊断和预后的意识,干扰素(IFN)-α治疗引起的副作用以及药物滥用有关。但是,观察到CHC患者的代谢变化已导致推测丙型肝炎病毒(HCV)对脑功能有直接作用。这项研究旨在阐明CHC是否与特定的焦虑或情绪障碍相关,而与混杂因素无关。方法患者队列:连续患者,135例CHC和76例慢性乙型肝炎(CHB)。排除标准:先前使用IFN-α的治疗,HCV和乙型肝炎病毒的共同感染,人类免疫缺陷病毒的感染,药物或酒精的滥用或恶性肿瘤。对照:从先前流行病学研究的数据库中随机提取的无肝炎证据的受试者;他们被分为两组(分别为540名(332名男性)和304名(220名男性))作为CHC和CHB患者的对照组。精神科诊断是由医师根据DSM-IV标准通过简化的《综合国际诊断访谈》来制定的。结果与CHB或对照组相比,CHC的主要抑郁症(MDD)终生患病率更高。 CHB和对照组之间MDD的风险在统计学上没有差异。与对照组相比,CHC组和CHB组均表现出明显更高的惊恐发作频率。将CHC或CHB与对照进行比较,在一般性焦虑症和社交恐惧症的患病率中未观察到统计学差异。结论本研究为根据明确的国际标准诊断出的CHC与MDD之间的关联提供了第一个证据。这种关联与IFN-α的治疗无关,不受药物或酒精滥用的影响。相比之下,焦虑症似乎并不与CHC特定相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号